BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Decara J, Rivera P, López-Gambero AJ, Serrano A, Pavón FJ, Baixeras E, Rodríguez de Fonseca F, Suárez J. Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases. Front Pharmacol 2020;11:730. [PMID: 32536865 DOI: 10.3389/fphar.2020.00730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Venkataraman B, Almarzooqi S, Raj V, Dudeja PK, Bhongade BA, Patil RB, Ojha SK, Attoub S, Adrian TE, Subramanya SB, Mandard S. α-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR-γ Transcription Factor: In Vivo and In Vitro Study. PPAR Research 2022;2022:1-22. [DOI: 10.1155/2022/5498115] [Reference Citation Analysis]
2 Sanjay, Sharma A, Lee HJ. Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders. Biomedicines 2021;9:1914. [PMID: 34944727 DOI: 10.3390/biomedicines9121914] [Reference Citation Analysis]
3 Kim JT, Napier DL, Kim J, Li C, Lee EY, Weiss HL, Wang Q, Evers BM. Ketogenesis alleviates TNFα-induced apoptosis and inflammatory responses in intestinal cells. Free Radic Biol Med 2021;172:90-100. [PMID: 34087430 DOI: 10.1016/j.freeradbiomed.2021.05.032] [Reference Citation Analysis]
4 Stark JM, Coquet JM, Tibbitt CA. The Role of PPAR-γ in Allergic Disease. Curr Allergy Asthma Rep 2021;21:45. [PMID: 34697644 DOI: 10.1007/s11882-021-01022-x] [Reference Citation Analysis]
5 Lian J, Casari I, Falasca M. Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract. Pharmacol Res 2021;175:106025. [PMID: 34883211 DOI: 10.1016/j.phrs.2021.106025] [Reference Citation Analysis]
6 Venkataraman B, Almarzooqi S, Raj V, Alhassani AT, Alhassani AS, Ahmed KJ, Subramanian VS, Ojha SK, Attoub S, Adrian TE, Subramanya SB. Thymoquinone, a Dietary Bioactive Compound, Exerts Anti-Inflammatory Effects in Colitis by Stimulating Expression of the Colonic Epithelial PPAR-γ Transcription Factor. Nutrients 2021;13:1343. [PMID: 33920708 DOI: 10.3390/nu13041343] [Reference Citation Analysis]
7 Guo C, Zhang Y, Ling T, Zhao C, Li Y, Geng M, Gai S, Qi W, Luo X, Chen L, Zhang T, Wang N. Chitosan Oligosaccharides Alleviate Colitis by Regulating Intestinal Microbiota and PPARγ/SIRT1-Mediated NF-κB Pathway. Marine Drugs 2022;20:96. [DOI: 10.3390/md20020096] [Reference Citation Analysis]
8 Kim W, Jang JH, Zhong X, Seo H, Surh YJ. 15-Deoxy-△12,14-Prostaglandin J2 Promotes Resolution of Experimentally Induced Colitis. Front Immunol 2021;12:615803. [PMID: 33633749 DOI: 10.3389/fimmu.2021.615803] [Reference Citation Analysis]
9 Shi Y, He W, Zhong M, Yu M. MIN score predicts primary response to infliximab/adalimumab and vedolizumab therapy in patients with inflammatory bowel diseases. Genomics 2021;113:1988-98. [PMID: 33872704 DOI: 10.1016/j.ygeno.2021.04.011] [Reference Citation Analysis]
10 Galiazzo G, Tagliavia C, Giancola F, Rinnovati R, Sadeghinezhad J, Bombardi C, Grandis A, Pietra M, Chiocchetti R. Localisation of Cannabinoid and Cannabinoid-Related Receptors in the Horse Ileum. J Equine Vet Sci 2021;104:103688. [PMID: 34416995 DOI: 10.1016/j.jevs.2021.103688] [Reference Citation Analysis]
11 Lago-Fernandez A, Zarzo-Arias S, Jagerovic N, Morales P. Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System. Int J Mol Sci 2021;22:1001. [PMID: 33498245 DOI: 10.3390/ijms22031001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Lochhead P, Khalili H, Ananthakrishnan AN, Burke KE, Richter JM, Sun Q, Grandjean P, Chan AT. Plasma concentrations of perfluoroalkyl substances and risk of inflammatory bowel diseases in women: A nested case control analysis in the Nurses' Health Study cohorts. Environ Res 2021;:112222. [PMID: 34662575 DOI: 10.1016/j.envres.2021.112222] [Reference Citation Analysis]
13 El-atawneh S, Goldblum A. Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors. Front Pharmacol 2022;13:812745. [DOI: 10.3389/fphar.2022.812745] [Reference Citation Analysis]
14 Suau R, Pardina E, Domènech E, Lorén V, Manyé J. The complex relationship between microbiota, immune response and creeping fat in Crohn's disease. J Crohns Colitis 2021:jjab159. [PMID: 34528668 DOI: 10.1093/ecco-jcc/jjab159] [Reference Citation Analysis]
15 Tovar R, Gavito AL, Vargas A, Soverchia L, Hernandez-Folgado L, Jagerovic N, Baixeras E, Ciccocioppo R, Rodríguez de Fonseca F, Decara J. Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity. Nutrients 2021;13:2589. [PMID: 34444748 DOI: 10.3390/nu13082589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Gao H, Li Y, Chen X. Interactions between nuclear receptors glucocorticoid receptor α and peroxisome proliferator-activated receptor α form a negative feedback loop. Rev Endocr Metab Disord 2022. [PMID: 35476174 DOI: 10.1007/s11154-022-09725-w] [Reference Citation Analysis]